PMA supplement

P930021 S009: EMDOGAIN

FDA PMA supplement · Special (Immediate Track) · The Straumann Company

Key facts

Original PMA P930021
Supplement number S009
Supplement type Special (Immediate Track)
Reason for the supplement Labeling Change - Indications/instructions/shelf life/tradename
Trade name EMDOGAIN
Generic name Biologic material, dental
Applicant The Straumann Company
Product code NQA
Received date Apr 11, 2006
Decision date Apr 24, 2006

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements